Wednesday, January 6, 2021
11:06 AM EST – Cybin Inc. : Provided an update on its on its eight patent filings, which cover the Company’s novel therapeutics, delivery mechanisms and treatment regiments. Cybin’s updated corporate presentation will be available at www.cybin.com. The Company is also pleased to announce that it intends to expand the development of its therapeutics program to include, in addition to psilocybin, psychedelic compounds such as DMT, psilocybin analogues and a range of tryptamines and phenylethylamines which are expected to have improved pharmacokinetic profiles, while retaining the efficacy of the original molecules. In addition, the Company intends to build a database of molecules and their chemically synthesized pathways for use in the pharmaceutical industry. Cybin Inc. (O.CLXPF) shares were up 5.47 percent at 1.38.
Stocks in Play: Cybin Inc. , Wed, 06 Jan 2021 11:15:02 EST